Steve N. Slilaty
Chief Executive Officer at Sunshine Biopharma Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 1 board, counting each seat separately. Longest: Sunshine Biopharma Inc., 2 years.
Sunshine Biopharma Inc.
Director · Chief Executive Officer
Chief executive roles
Sunshine Biopharma Inc.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 4, 2024 | Sunshine Biopharma Inc. | Open-market purchase | +100,000 | $0.10 | $10,000 |
| Feb 8, 2024 | Sunshine Biopharma Inc. | Open-market purchase | +20,000 | $0.10 | $2,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.